3 completed. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Haemophilus Influenzae Type b Immunisation: new trials by email Literature Review of Haemophilus Influenzae Type b Immunisation trials Research Report on Haemophilus Influenzae Type b Immunisation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Post-marketing Surveillance Study for the Safety of a DTaP-IPV- HB-PRP~T Vaccine in Republic of Korea DTaP-IPV-Hep B-PRP-T combined vaccine - Hepatitis B, Haemophilus Influenzae Type b Immunisation | Completed | Sanofi Pasteur, a Sanofi Company | 713 | 2025-01-17 | 2026-02-18 | |
| Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus), DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b), Inactivated Poliomyelitis Vaccine - Pertussis Immunisation, Diphtheria Immunisation | Phase 3 | Completed | Sanofi Pasteur, a Sanofi Company | 460 | 2020-06-28 | 2025-09-22 |
| Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants Pneumococcal Conjugate Vaccine formulation 1, Pneumococcal Conjugate Vaccine formulation 2, Pneumococcal Conjugate Vaccine formulation 3 - Pneumococcal Immunisation, Diphtheria Immunisation | Phase 2 | Completed | Sanofi Pasteur, a Sanofi Company | 852 | 2020-05-22 | 2025-09-08 |
Hepatitis B (1)
Blood-Borne Infections (1) · Communicable Diseases (1) · DNA Virus Infections (1) · Digestive System Diseases (1) · Hepadnaviridae Infections (1) · Hepatitis (1) · Hepatitis, Viral, Human (1) · Infections (1) · Liver Diseases (1) · Virus Diseases (1)
13-valent pneumococcal vaccine (2) · Tetanus Toxoid (2) · CRM197 (non-toxic variant of diphtheria toxin) (1) · Chickenpox Vaccine (1) · DTaP-IPV-HB-PRP-T vaccine (1) · Diphtheria Toxoid (1) · Engerix-B (1) · Hepatitis B Surface Antigens (1) · Hepatitis B Vaccines (1) · Herpes Zoster Vaccine (1) · Measles-Mumps-Rubella Vaccine (1) · Poliovirus Vaccine, Inactivated (1) · RIX4414 vaccine (1) · RotaTeq (1) · Rotavirus Vaccines (1)
Sanofi Pasteur, a Sanofi Company (3)
Canada (1) · Honduras (1) · Puerto Rico (1) · South Korea (1) · Thailand (1) · United States (1)